Pages that link to "Q36838588"
Jump to navigation
Jump to search
The following pages link to Metabolic syndrome and NASH. (Q36838588):
Displaying 50 items.
- Role of stem cells during diabetic liver injury (Q26773551) (← links)
- Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal (Q26783344) (← links)
- Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease (Q27021700) (← links)
- Per-Arnt-Sim Kinase (PASK): An Emerging Regulator of Mammalian Glucose and Lipid Metabolism (Q28085060) (← links)
- Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease (Q28259585) (← links)
- Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. (Q30376120) (← links)
- Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease (Q30479198) (← links)
- Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment (Q30484122) (← links)
- Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration (Q33543381) (← links)
- An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway (Q33819857) (← links)
- Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis (Q33944689) (← links)
- Alzheimer's disease is type 3 diabetes-evidence reviewed (Q34020000) (← links)
- Genetic determinants of hepatic steatosis in man (Q34646183) (← links)
- The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. (Q35090416) (← links)
- Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome (Q35872059) (← links)
- Postprandial Responses to Lipid and Carbohydrate Ingestion in Repeated Subcutaneous Adipose Tissue Biopsies in Healthy Adults. (Q35894983) (← links)
- Brain metabolic dysfunction at the core of Alzheimer's disease (Q35997881) (← links)
- Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. (Q36473562) (← links)
- Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease (Q36502250) (← links)
- Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease (Q36623024) (← links)
- Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats. (Q36841315) (← links)
- Evaluation and management of obesity-related nonalcoholic fatty liver disease (Q36898693) (← links)
- Low educational status, smoking, and multidisciplinary team experience predict hospital length of stay after bariatric surgery (Q36973504) (← links)
- Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients (Q36996996) (← links)
- Non alcoholic fatty liver disease and metabolic syndrome. (Q37078311) (← links)
- High glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα/ABCA1-regulated lipid raft reorganization in SK-N-MC cells (Q37405573) (← links)
- Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice (Q37444112) (← links)
- Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. (Q37602608) (← links)
- Metabolic syndrome and risk factors for non-alcoholic fatty liver disease (Q38000540) (← links)
- Hepatic steatosis and steatohepatitis: Are they really two distinct entities? (Q38224490) (← links)
- Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride (Q38443746) (← links)
- Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome (Q41697003) (← links)
- Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease (Q42097807) (← links)
- Pentoxifylline for steatohepatitis: Magic bullet or smoking gun? (Q42734634) (← links)
- Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population (Q43225410) (← links)
- Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. (Q45789410) (← links)
- Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study (Q47555750) (← links)
- Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice (Q47718804) (← links)
- Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease (Q47804370) (← links)
- circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling (Q49387786) (← links)
- Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. (Q50134501) (← links)
- The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease (Q51321244) (← links)
- Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease. (Q52722291) (← links)
- Clinical features and natural history of hepatocellular adenomas: the impact of obesity (Q53232783) (← links)
- Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. (Q54317961) (← links)
- Investigation of common and rare genetic variation in the BAMBI genomic region in light of human obesity. (Q54649891) (← links)
- Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016 (Q58802116) (← links)
- Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children (Q62066939) (← links)
- Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis (Q64055244) (← links)
- Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases (Q64118356) (← links)